bupropion · BUPROPION HYDROCHLORIDE 300 mg/1 · Tablet, Extended Release · Oral · Zydus Pharmaceuticals USA Inc.
NDC 68382-0354-05 · 500 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $0.4489 per unit over the past year.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Proficient Rx LP | BUPROPION HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | BUPROPION HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | BUPROPION HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | BUPROPION HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | BUPROPION HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "bupropion — NDC 68382-0354-05," retrieved September 3, 2026, https://drugdashboards.com/drug/68382035405.
Free to cite with attribution — see how the data is put together.